Paromomycin (Paromomycin Sulfate) - Summary

PAROMOMYCIN SUMMARY

Paromomycin Sulfate
Capsules, USP

Paromomycin sulfate is a broad spectrum antibiotic produced by Streptomyces riomosus var. paromomycinus. It is a white, amorphous, stable, water-soluble product.

Paromomycin sulfate is indicated for intestinal amebiasis—acute and chronic (NOTE—It is not effective in extraintestinal amebiasis); management of hepatic coma—as adjunctive therapy.

PAROMOMYCIN NEWS HIGHLIGHTS

Published Studies Related to Paromomycin

Injectable paromomycin for Visceral leishmaniasis in India. [2007.06.21]

Comparison between the efficacy of photodynamic therapy and topical paromomycin in the treatment of Old World cutaneous leishmaniasis: a placebo-controlled, randomized clinical trial. [2006.09]

Comparison of topical paromomycin sulfate (twice/day) with intralesional meglumine antimoniate for the treatment of cutaneous leishmaniasis caused by L. major. [2005.03]

Efficacy of paromomycin ointment in the treatment of cutaneous leishmaniasis: results of a double-blind, randomized trial in Isfahan, Iran. [2005.01]

more>>

Clinical Trials Related to Paromomycin

Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis [Completed]

A Double-Blind, Placebo-Controlled Trial of Paromomycin for Treatment of Cryptosporidiosis in Patients With Advanced HIV Disease and CD4 Counts Under 150 Cells/mm3 [Completed]

Treatment of Chronic Cryptosporidiosis in AIDS Patients [Terminated]

Controlled Study to Evaluate WR 279,396 vs. Paromomycin Alone to Treat Cutaneous Leishmaniasis (in Tunisia) [Recruiting]

An Open Lable Randomised Study to Assess the Safety and Efficacy of Short Course Paromomycin in Visceral Leishmaniasis [Recruiting]

more>>